PRTN3 and rheumatoid arthritis: Therefore, the determination of multiple antibodies and isotypes, even if they are not highly specific for RA, does not only reduce the number of seronegative (i.e., IgG-ACPA and RF negative) patients but seems to have also prognostic value with respect to disease progression and response to therapy, a matter that is currently under investigation.